Literature DB >> 11381111

Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia.

M F Egan1, T E Goldberg, B S Kolachana, J H Callicott, C M Mazzanti, R E Straub, D Goldman, D R Weinberger.   

Abstract

Abnormalities of prefrontal cortical function are prominent features of schizophrenia and have been associated with genetic risk, suggesting that susceptibility genes for schizophrenia may impact on the molecular mechanisms of prefrontal function. A potential susceptibility mechanism involves regulation of prefrontal dopamine, which modulates the response of prefrontal neurons during working memory. We examined the relationship of a common functional polymorphism (Val(108/158) Met) in the catechol-O-methyltransferase (COMT) gene, which accounts for a 4-fold variation in enzyme activity and dopamine catabolism, with both prefrontally mediated cognition and prefrontal cortical physiology. In 175 patients with schizophrenia, 219 unaffected siblings, and 55 controls, COMT genotype was related in allele dosage fashion to performance on the Wisconsin Card Sorting Test of executive cognition and explained 4% of variance (P = 0.001) in frequency of perseverative errors. Consistent with other evidence that dopamine enhances prefrontal neuronal function, the load of the low-activity Met allele predicted enhanced cognitive performance. We then examined the effect of COMT genotype on prefrontal physiology during a working memory task in three separate subgroups (n = 11-16) assayed with functional MRI. Met allele load consistently predicted a more efficient physiological response in prefrontal cortex. Finally, in a family-based association analysis of 104 trios, we found a significant increase in transmission of the Val allele to the schizophrenic offspring. These data suggest that the COMT Val allele, because it increases prefrontal dopamine catabolism, impairs prefrontal cognition and physiology, and by this mechanism slightly increases risk for schizophrenia.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11381111      PMCID: PMC34453          DOI: 10.1073/pnas.111134598

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  60 in total

1.  Use of unlinked genetic markers to detect population stratification in association studies.

Authors:  J K Pritchard; N A Rosenberg
Journal:  Am J Hum Genet       Date:  1999-07       Impact factor: 11.025

2.  Sibling-based tests of linkage and association for quantitative traits.

Authors:  D B Allison; M Heo; N Kaplan; E R Martin
Journal:  Am J Hum Genet       Date:  1999-06       Impact factor: 11.025

3.  Neuropsychological assessment of monozygotic twins discordant for schizophrenia.

Authors:  T E Goldberg; J D Ragland; E F Torrey; J M Gold; L B Bigelow; D R Weinberger
Journal:  Arch Gen Psychiatry       Date:  1990-11

4.  D1 dopamine receptors in prefrontal cortex: involvement in working memory.

Authors:  T Sawaguchi; P S Goldman-Rakic
Journal:  Science       Date:  1991-02-22       Impact factor: 47.728

5.  A network model of catecholamine effects: gain, signal-to-noise ratio, and behavior.

Authors:  D Servan-Schreiber; H Printz; J D Cohen
Journal:  Science       Date:  1990-08-24       Impact factor: 47.728

6.  Linkage strategies for genetically complex traits. I. Multilocus models.

Authors:  N Risch
Journal:  Am J Hum Genet       Date:  1990-02       Impact factor: 11.025

7.  Linkage disequilibrium on the COMT gene in French schizophrenics and controls.

Authors:  M de Chaldée; C Laurent; F Thibaut; M Martinez; D Samolyk; M Petit; D Campion; J Mallet
Journal:  Am J Med Genet       Date:  1999-10-15

8.  The effect of amphetamine on regional cerebral blood flow during cognitive activation in schizophrenia.

Authors:  D G Daniel; D R Weinberger; D W Jones; J R Zigun; R Coppola; S Handel; L B Bigelow; T E Goldberg; K F Berman; J E Kleinman
Journal:  J Neurosci       Date:  1991-07       Impact factor: 6.167

Review 9.  Probing prefrontal function in schizophrenia with neuropsychological paradigms.

Authors:  T E Goldberg; D R Weinberger
Journal:  Schizophr Bull       Date:  1988       Impact factor: 9.306

10.  Lamina-specific alterations in the dopamine innervation of the prefrontal cortex in schizophrenic subjects.

Authors:  M Akil; J N Pierri; R E Whitehead; C L Edgar; C Mohila; A R Sampson; D A Lewis
Journal:  Am J Psychiatry       Date:  1999-10       Impact factor: 18.112

View more
  751 in total

Review 1.  Impact of molecular medicine on neuropsychiatry: the clinician's perspective.

Authors:  J M Ryan; R Loy; P N Tariot
Journal:  Curr Psychiatry Rep       Date:  2001-10       Impact factor: 5.285

Review 2.  Functional brain mapping of psychopathology.

Authors:  G D Honey; P C Fletcher; E T Bullmore
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-04       Impact factor: 10.154

3.  Transcriptional profiling in the human prefrontal cortex: evidence for two activational states associated with cocaine abuse.

Authors:  E Lehrmann; J Oyler; M P Vawter; T M Hyde; B Kolachana; J E Kleinman; M A Huestis; K G Becker; W J Freed
Journal:  Pharmacogenomics J       Date:  2003       Impact factor: 3.550

Review 4.  Linkage and association studies of schizophrenia.

Authors:  Peter McGuffin; Kopal Tandon; Alejandro Corsico
Journal:  Curr Psychiatry Rep       Date:  2003-06       Impact factor: 5.285

Review 5.  The genetics of sensory gating deficits in schizophrenia.

Authors:  Robert Freedman; Ann Olincy; Randall G Ross; Merilyne C Waldo; Karen E Stevens; Lawrence E Adler; Sherry Leonard
Journal:  Curr Psychiatry Rep       Date:  2003-06       Impact factor: 5.285

Review 6.  Cognitive effects of nicotine: genetic moderators.

Authors:  Aryeh I Herman; Mehmet Sofuoglu
Journal:  Addict Biol       Date:  2010-04-29       Impact factor: 4.280

7.  Association of Catechol-O-methyltransferase val/met polymorphism with cognitive function in Gilles de la Tourette syndrome patients.

Authors:  Weidong Ji; Ning Li; Kang Ju; Hong Zheng; Chuang Yang; Ping Xu; Silu Chen; Aiai Cao; Xue Chen; Lanting Guo
Journal:  Neurol Sci       Date:  2014-11-04       Impact factor: 3.307

8.  COMT influences on prefrontal and striatal blood oxygenation level-dependent responses during working memory among individuals with schizophrenia, their siblings, and healthy controls.

Authors:  Alan Ceaser; John G Csernansky; Deanna M Barch
Journal:  Cogn Neuropsychiatry       Date:  2012-10-03       Impact factor: 1.871

9.  Interaction of dopamine system genes and cognitive functions in patients with schizophrenia and their relatives and in healthy subjects from the general population.

Authors:  M V Alfimova; V E Golimbet; I K Gritsenko; T V Lezheiko; L I Abramova; M A Strel'tsova; I V Khlopina; R Ebstein
Journal:  Neurosci Behav Physiol       Date:  2007-09

Review 10.  Genetic, transcriptomic, and epigenetic studies of HIV-associated neurocognitive disorder.

Authors:  Andrew J Levine; Stella E Panos; Steve Horvath
Journal:  J Acquir Immune Defic Syndr       Date:  2014-04-01       Impact factor: 3.731

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.